ArticleWorld journal of urology2024

Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma.

Angelika Borkowetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.